Neutralization of Chlamydia trachomatis: kinetics and stoichiometry
- PMID: 1855982
- PMCID: PMC258065
- DOI: 10.1128/iai.59.8.2624-2630.1991
Neutralization of Chlamydia trachomatis: kinetics and stoichiometry
Abstract
Monoclonal antibodies to the major outer membrane protein of Chlamydia trachomatis were used to neutralize C. trachomatis infectivity in HeLa 229 cells and to determine the kinetics and stoichiometry of the reaction. In vitro neutralization of C. trachomatis infectivity proceeded as a first-order reaction and required an activation energy of approximately 20 kcal/mol (ca. 84 kJ/mol). The rate of neutralization was linear with respect to antibody concentration and reaction temperature. The efficiency of neutralization decreased exponentially as the ratio of noninfective to infective chlamydiae increased in the antigen preparation. The neutralization assay was also significantly affected by reaction parameters such as the reaction volume and the duration of incubation. Stoichiometric calculations showed that an average ratio of 10(3) and 10(4) immunoglobulin molecules per chlamydial particle was required to yield 50% neutralization by monoclonal antibodies specifying serovar-specific and species-specific epitopes, respectively. The implications of these findings for vaccine design and for the role of the major outer membrane protein in the pathogenesis of chlamydial infections are discussed.
Similar articles
-
Effects of antibody isotype and host cell type on in vitro neutralization of Chlamydia trachomatis.Infect Immun. 1993 Feb;61(2):498-503. doi: 10.1128/iai.61.2.498-503.1993. Infect Immun. 1993. PMID: 8423079 Free PMC article.
-
In vitro neutralization of Chlamydia trachomatis with monoclonal antibody to an epitope on the major outer membrane protein.Infect Immun. 1984 Nov;46(2):484-8. doi: 10.1128/iai.46.2.484-488.1984. Infect Immun. 1984. PMID: 6209221 Free PMC article.
-
Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis.J Immunol. 1987 Jan 15;138(2):575-81. J Immunol. 1987. PMID: 3540122
-
In vitro neutralization of Chlamydia trachomatis by monovalent Fab antibody specific to the major outer membrane protein.Infect Immun. 1991 Aug;59(8):2843-5. doi: 10.1128/iai.59.8.2843-2845.1991. Infect Immun. 1991. PMID: 1713202 Free PMC article.
-
Chlamydial polymorphic membrane proteins: regulation, function and potential vaccine candidates.Virulence. 2016;7(1):11-22. doi: 10.1080/21505594.2015.1111509. Epub 2015 Nov 18. Virulence. 2016. PMID: 26580416 Free PMC article. Review.
Cited by
-
Characterization of a neutralizing monoclonal antibody directed at the lipopolysaccharide of Chlamydia pneumoniae.Infect Immun. 1998 Aug;66(8):3848-55. doi: 10.1128/IAI.66.8.3848-3855.1998. Infect Immun. 1998. PMID: 9673271 Free PMC article.
-
A Novel Flow Cytometric Approach for the Quantification and Quality Control of Chlamydia trachomatis Preparations.Pathogens. 2021 Dec 12;10(12):1617. doi: 10.3390/pathogens10121617. Pathogens. 2021. PMID: 34959572 Free PMC article.
-
Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector.PLoS Pathog. 2011 Sep;7(9):e1002258. doi: 10.1371/journal.ppat.1002258. Epub 2011 Sep 22. PLoS Pathog. 2011. PMID: 21966270 Free PMC article.
-
Genetic transformation of a clinical (genital tract), plasmid-free isolate of Chlamydia trachomatis: engineering the plasmid as a cloning vector.PLoS One. 2013;8(3):e59195. doi: 10.1371/journal.pone.0059195. Epub 2013 Mar 18. PLoS One. 2013. PMID: 23527131 Free PMC article.
-
Population-based genetic and evolutionary analysis of Chlamydia trachomatis urogenital strain variation in the United States.J Bacteriol. 2004 Apr;186(8):2457-65. doi: 10.1128/JB.186.8.2457-2465.2004. J Bacteriol. 2004. PMID: 15060049 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources